After trouble in India, Nestle's instant noodles brand, Maggi has now come under the scanner of the US Food and Drug Administration (FDA) which is now testing the samples.

The spokeswoman of the food company has said that Nestle does not import, market or distribute Maggi noodles in the US.

Before Maggi instant noodles were found to be "unsafe", US food-safety inspectors had considered hundreds of made-in-India snacks not fit for sale in America. According to a report by The Wall Street Journal the data on the website of the US Food and Drug Administration indicates that in the first five months of 2015, it banned more snack imports from India than from any other country.

On 5 June, FSSAI ordered Nestle India to "stop further production, processing, import, distribution and sale" of all nine variations of Maggi as they had been found unfit for human consumption.

According to FSSAI, the noodles contain lead beyond the maximum permissible levels of 2.5 parts per million (ppm), the package reading 'No added MSG' (monosodium glutamate) is misleading and a non-standardized food product Maggi Oats Masala Noodles with Tastemaker was released in the market without risk assessment and grant of product approval.

The lab in Delhi which analyzed the instant noodles reportedly did not have the technology, expertise or even the accreditation to do the tests in time.